Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Sources Sought opportunity from Department Of Defense was posted on October 12, 2017. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

3M Outpatient Prospective Payment System Pricer Software License and Maintenance

Closed
DHA-SS-18-3MFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

NAICS

511210 - Software Publishers

Place of Performance

16401 East Centretech Parkway Aurora, Colorado 80011 United States, CO, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
Contacts2 people available
OfficeAURORA, CO, 80011, USA
Office AddressAURORA, CO, 80011, USA
Contacts
Sherril S LightContract Specialist

Full Description

Show more
Synopsis: DHA-SS-18-3M Outpatient Prospective Payment System (OPPS) PRICER software licenses and maintenance A. Background DHA is statutorily mandated to follow Centers for Medicare and Medicaid Services (CMS) reimbursement methodologies where practicable. As a result, DHA has worked in conjunction with 3M to develop and implement a prospective payment system for processing hospital outpatient claims. OPPS is comprised of two software programs: 1. The first program is the OCE designed for editing and processing hospital outpatient claims. There is a Letter of Agreement between 3M and DHA (then TRICARE Management Activity (TMA)) for the development and maintenance of a TRICARE-specific OCE at no cost to the Government. Since 3M maintains CMS' OCE, they agreed to develop and maintain a similar TRICARE OCE with the understanding that they would retain proprietary rights to the software. 2. The second program is the Pricer that determines how to price claims based on the output from the OCE. Due to the complexity of TRICARE's OPPS, DHA decided to license a commercial mainframe TRICARE Pricer to include quarterly updates that coincide with those of CMS. (a) TRICARE is statutorily mandated to follow CMS' OPPS reimbursement methodology where practicable. It is critical the contractor have access to advance copies of CMS' OCE changes in order to meet quarterly updates. In accordance with 32 C.F.R. 199.1 (c)(2)(ii), CMS has agreed to allow 3M to provide TRICARE with advance copies of OCE changes due to the delegated authority given to the Assistant Secretary for Health, Department of Health and Human Services (DHHS), to consult with the Secretary of Defense, or a designee and to approve and issue joint regulations implementing 10. U.S.C. chapter 55. (b) TMA requires a license for a mainframe version of the TRICARE Pricer software in order to ensure: i. Uniformity of pricing among regions ii. Programmatic control to ensure consistent and timely updates (requires quarterly updating of pricing files) iii. Consistency with CMS (Centers for Medicare and Medicaid Services) pricing methodologies iv. Integration between TRICARE specific OCE and Pricer software v. Portability of Pricer software for future contract transitions B. Purpose of this Sources Sought The purpose of this Sources Sought is to conduct market research to determine if there are vendors offering DHA's requirements for licensing a commercial mainframe version of a TRICARE-specific OPPS Pricer that can be fully integrated with the 3M OCE, and licensing PC versions that includes both the OCE and Pricer software for auditing and verification of accuracy of payment for hospital outpatient claims. This effort will provide for the licensing, maintenance and updating of both the mainframe and PC software versions. The maintenance, to include quarterly updates and any revisions to those updates, this will have a 12 month period of performance. C. Deliverables Description: TRICARE Mainframe Pricer Software License-includes maintenance, such as, technical support, debugging and upgrades. PC Version, 3M Core Grouping Software with TRICARE OPPS Grouping and Reimbursement License -includes maintenance, such as technical support, debugging, and upgrades. Installation/User Manuals for Mainframe and PC Software -Included with Consists of manuals support the mainframe software, quarterly licenses updates that include software, coding, and prices. 3M Outpatient Pricer Tables for PC Version Software Consists of Included with Pricer Tables for the PC software including quarterly updates. D. How to Respond THIS IS A SOURCES SOUGHT ONLY. Please do not submit a quote or specific dollar amounts. This RFI is issued solely for information and acquisition planning purposes. It does not constitute a solicitation nor does it restrict the Government as to the ultimate acquisition approach. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Any contract that might be awarded based on information received or derived from this market research will be the outcome of a competitive process. Responders are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this RFI. All costs associated with responding to this RFI will be solely at the interested vendor's expense. Not responding to this RFI does not preclude participation in any future Request for Quotation (RFQ), if any is issued. The Government may issue a formal solicitation on the Federal Business Opportunities (fbo.gov) website at a future date. If the Government issues a solicitation, the Government will conduct any source selection in accordance with the Federal Acquisition Regulation (FAR), as supplemented. Any future information on this acquisition (statement of work, specifications, solicitation, etc.) will be posted on www.fbo.gov. It is the responsibility of the prospective offeror to review this site regularly for updates and/or changes. DHA will not respond to questions about the policy issues raised in this notice. The formal closing date for this RFI and for the submission of responses is October 27, 2017, 1:00pm MT. All responses shall be submitted electronically using PDF, HTML, MS Word or PowerPoint formats with subject "DHA-SS-18-3M OPPS PRICER Response" to the following Email address: thomas.e.poplin3.ctr@mail.com and sherril.s.light.civ@mail.mil. Please provide the following information: Company name, mailing address; and the name, phone number, fax number, and email of the designated point of contact. Please identify any available GSA contracts which DHA may use to place an order, including NAICS codes and SINs. Include any applicable small business categories.

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 811210
New
Federal
Zeiss Meditec Ophthalmology Equipment Maintenance
Solicitation # HT940627QE003
Solicitation HT940627QE003 is a Request for Quote issued by the Defense Health Agency, Healthcare Contracting Division-Southeast, for a firm-fixed-price contract to provide full-service maintenance for Zeiss MediTec ophthalmology equipment at the Naval Medical Center Camp Lejeune in North Carolina. The scope of work includes regularly scheduled preventative maintenance, timely onsite repairs, and software updates for specific devices, including the CIRRUS 5000, IOLMASTER 700, HFA3 B60, and ATLAS 900. All services must be performed according to manufacturer recommendations and applicable FDA regulations. The contract consists of a base period from December 1, 2026, to November 30, 2027, with four subsequent option periods extending the potential performance through November 30, 2031. This procurement is a total small business set-aside under NAICS code 811210. Award will be made based on the Lowest Priced Technically Acceptable (LPTA) basis, where technical capability is evaluated independently of price. Offerors must submit two separate volumes: Volume I for technical capability, which must describe the functional approach and methodology without identifying company names or logos, and Volume II for comprehensive pricing. Quotes are due by 8:00 am Eastern Time on October 29, 2026. Payment and invoicing will be processed electronically through the Wide Area WorkFlow system.
Electronic and Precision Equipment Repair and Maintenance

POSTED

2 days ago

DEADLINE

in 8 days
View Details
NAICS: 541715
New
Federal
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Solicitation # HT9427-26-R-E020
The Defense Health Agency Contracting Activity is seeking a single award for the development of a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This product must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent the spread of organisms and systemic infections in combat scenarios. The project aims to advance technologies from a preferred Technology Readiness Level of 5 or higher to a final state of TRL 7 or 8, culminating in mandatory U.S. Food and Drug Administration approval or clearance. The scope of work includes preclinical testing, human clinical trials, and the submission of regulatory packages such as New Drug Applications or Premarket Approval Applications. This procurement is conducted under prototype Other Transaction Authority 10 U.S.C. 4022, meaning standard FAR and DFARS regulations do not apply unless expressly referenced. The estimated period of performance is 48 months, divided into three primary objectives: prototype demonstration, clinical studies and regulatory submissions, and final FDA clearance. Proposals are due by November 6, 2026, and must be submitted in three distinct volumes covering technical approach, management capability, and administrative cost and price. To be eligible, offerors must be registered in the System for Award Management and meet specific criteria, such as being a nontraditional defense contractor or a small business.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

2 days ago

DEADLINE

in 16 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS